Metabolomics and microbiomics: dietary and environmental factors in cancer
Tuesday 2 December 2025
07:00 [PST] 10:00 [EST] 15:00 [GMT]
Explore cutting-edge bioanalytical approaches in colorectal cancer and gut microbiome research, including dried blood spot metabolomics, colorectal cancer metabolome mapping, liver metastasis profiling and multi-omics integration.
This webinar presents innovative bioanalytical approaches in colorectal cancer and gut microbiome research, emphasizing large-scale human population studies. The presentation will cover dried blood spot metabolomics for high-throughput analyses, comprehensive colorectal cancer metabolome mapping, and liver metastasis profiling to reveal tumor heterogeneity and drug resistance. Host–microbe co-metabolism will also be explored, linking gut microbial activity to human metabolic pathways. Designed for cancer researchers, metabolomics and microbiome scientists, clinical investigators and public health professionals, this webinar will highlight innovative strategies to uncover novel metabolic mechanisms in human health and disease.
What will you learn?
- Untargeted metabolomics approaches to uncover novel metabolic pathways in human health and disease.
- Large-scale human studies enabling comprehensive colorectal cancer metabolome mapping and population-level insights.
- Profiling liver metastases to reveal metabolic differences across tumor sites.
- Dried blood spot metabolomics for robust, high-throughput sample analysis.
- Gut–microbiome and human–host co-metabolism integration to connect microbial activity with host metabolism.
Who may this interest?
- Cancer researchers focused on colorectal cancer and metastasis.
- Metabolomics and bioanalytical scientists interested in untargeted and large-scale analyses.
- Microbiome researchers studying host–microbe metabolic interactions.
- Clinical and translational scientists seeking insights from population-level metabolomics.
- Epidemiologists and public health researchers using innovative sample types like dried blood spots.
Abhishek Jain
Principal Investigator
Wadsworth Center, New York State Department of Health
Dr Abhishek Jain is a Principal Investigator at the New York State Department of Health (NY, USA). Previously a research faculty member at Yale School of Public Health (CT, USA), his research integrates LC–MS untargeted metabolomics, gut microbiome analyses, and human–host co-metabolism to uncover novel pathways in health and cancer. He created a colorectal cancer metabolome atlas from 800 patient samples, revealing tumor heterogeneity and mechanisms of EGFR inhibitor resistance in right- versus left-sided liver metastases. His work has expanded the Human Metabolome Database, helped to develop widely adopted dried blood spot metabolomics methods, and earned the Yale Research Impact Award, the NIH-NCATS KL2 Scholar grant, the Early Career Member Award from the International Metabolomics Society, the Outstanding Early Career Faculty Award from the Association of Clinical and Translational Science (DC, USA), and recognition from the Society of Surgical Oncology (IL, USA).